Loading...
EMBL

Embla Medical hf.CPSE:EMBLA Stock Report

Market Cap DKK 14.6b
Share Price
DKK 34.20
My Fair Value
DKK 37.4
8.6% undervalued intrinsic discount
1Y-3.7%
7D8.6%
Portfolio Value
​
View

Embla Medical hf.

CPSE:EMBLA Stock Report

Market Cap: DKK 14.6b

Embla Medical hf (EMBLA) Stock Overview

Provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. More details

EMBLA fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance4/6
Financial Health5/6
Dividends0/6

Rewards

Trading at 15.2% below our estimate of its fair value

Earnings are forecast to grow 14.39% per year

Earnings grew by 11.7% over the past year

Risk Analysis

No risks detected for EMBLA from our risk checks.

EMBLA Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

EMBL
Embla Medical hf

Digital Healthcare And Aging Trends Will Expand Opportunities

Key Takeaways Accelerated growth is expected from new product launches, Medicare expansion, and a strong global position in digital and emerging healthcare markets. Operational efficiencies, unified platforms, and expanding software-driven revenue streams support substantial long-term margin expansion and earnings stability.
View narrative
DKK 39.1
FV
12.5% undervalued intrinsic discount
9.74%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
EMBL
Embla Medical hf

Rising Regulatory And US Tariff Pressures Will Depress Market Prospects

Key Takeaways Rising regulatory demands, geopolitical risks, and healthcare pricing pressures are expected to increase costs and compress margins for Embla Medical hf. Limited geographic diversification and accelerating commoditization threaten Embla Medical's revenue stability and long-term profitability.
View narrative
DKK 28
FV
22.1% overvalued intrinsic discount
9.32%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
EMBL
Embla Medical hf

Analysts Lift Embla Medical hf Price Target on Stronger Growth and Improved Margins

Key Takeaways Product innovation, strategic acquisitions, and expanded reimbursement coverage position Embla Medical for long-term revenue growth and increased market share in advanced medical devices. Efficiency improvements, operating leverage, and rebranding are expected to enhance margins, earnings growth, and profitability despite near-term external challenges.
View narrative
DKK 37.4
FV
8.6% undervalued intrinsic discount
9.42%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
View Stock Community

Embla Medical hf. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Embla Medical hf
Historical stock prices
Current Share PriceDKK 34.20
52 Week HighDKK 38.00
52 Week LowDKK 25.01
Beta0.58
1 Month Change4.27%
3 Month Change5.56%
1 Year Change-3.66%
3 Year Change2.70%
5 Year Change-19.53%
Change since IPO521.82%

Recent News & Updates

Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Sep 23
Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Recent updates

Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Sep 23
Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Investors Interested In Embla Medical hf.'s (CPH:EMBLA) Earnings

Sep 03
Investors Interested In Embla Medical hf.'s (CPH:EMBLA) Earnings

Do Embla Medical hf's (CPH:EMBLA) Earnings Warrant Your Attention?

Aug 08
Do Embla Medical hf's (CPH:EMBLA) Earnings Warrant Your Attention?

Analysts Are Updating Their Embla Medical hf. (CPH:EMBLA) Estimates After Its Second-Quarter Results

Jul 25
Analysts Are Updating Their Embla Medical hf. (CPH:EMBLA) Estimates After Its Second-Quarter Results

Is Embla Medical hf (CPH:EMBLA) Using Too Much Debt?

Jul 10
Is Embla Medical hf (CPH:EMBLA) Using Too Much Debt?

Slowing Rates Of Return At Embla Medical hf (CPH:EMBLA) Leave Little Room For Excitement

Jun 10
Slowing Rates Of Return At Embla Medical hf (CPH:EMBLA) Leave Little Room For Excitement

A Look At The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

May 26
A Look At The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion

Apr 11
Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion

Here's Why Embla Medical hf (CPH:EMBLA) Can Manage Its Debt Responsibly

Mar 27
Here's Why Embla Medical hf (CPH:EMBLA) Can Manage Its Debt Responsibly

Embla Medical hf.'s (CPH:EMBLA) CEO Will Probably Find It Hard To See A Huge Raise This Year

Mar 06
Embla Medical hf.'s (CPH:EMBLA) CEO Will Probably Find It Hard To See A Huge Raise This Year

Investors Met With Slowing Returns on Capital At Embla Medical hf (CPH:EMBLA)

Feb 23
Investors Met With Slowing Returns on Capital At Embla Medical hf (CPH:EMBLA)
User avatar

Acquisition Of Fior & Gentz And New Product Launches Will Expand Neuro Orthotics Portfolio Into New Markets

Expansion into new markets with Fior & Gentz acquisition could boost revenue and market share through neuro orthotics.

Embla Medical hf. Just Missed EPS By 5.8%: Here's What Analysts Think Will Happen Next

Feb 09
Embla Medical hf. Just Missed EPS By 5.8%: Here's What Analysts Think Will Happen Next

A Look At The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Jan 25
A Look At The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

We Ran A Stock Scan For Earnings Growth And Embla Medical hf (CPH:EMBLA) Passed With Ease

Jan 03
We Ran A Stock Scan For Earnings Growth And Embla Medical hf (CPH:EMBLA) Passed With Ease

Shareholders Should Be Pleased With Embla Medical hf.'s (CPH:EMBLA) Price

Dec 16
Shareholders Should Be Pleased With Embla Medical hf.'s (CPH:EMBLA) Price

Embla Medical hf (CPH:EMBLA) Seems To Use Debt Quite Sensibly

Nov 30
Embla Medical hf (CPH:EMBLA) Seems To Use Debt Quite Sensibly

Results: Embla Medical hf. Beat Earnings Expectations And Analysts Now Have New Forecasts

Oct 25
Results: Embla Medical hf. Beat Earnings Expectations And Analysts Now Have New Forecasts

Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Oct 17
Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)

Do Embla Medical hf's (CPH:EMBLA) Earnings Warrant Your Attention?

Oct 02
Do Embla Medical hf's (CPH:EMBLA) Earnings Warrant Your Attention?

Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion

Aug 22
Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion

Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jul 26
Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)

Jul 17
Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)

Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

May 14
Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Apr 26
Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)

Apr 10
A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)

Is Össur hf (CPH:OSSR) Using Too Much Debt?

Mar 23
Is Össur hf (CPH:OSSR) Using Too Much Debt?

Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E

Jan 21
Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E

Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)

Jan 03
Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Nov 28
Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Nov 08
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

A Look At The Fair Value Of Össur hf. (CPH:OSSR)

Sep 23
A Look At The Fair Value Of Össur hf. (CPH:OSSR)

We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt

Aug 21
We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt

Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital

Jul 18
Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital

Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price

Jun 14
Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

May 19
Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

Mar 14
Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)

Jan 21
A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)

These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well

Dec 22
These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well

There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Dec 07
There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?

Sep 21
Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Sep 02
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Shareholder Returns

EMBLADK Medical EquipmentDK Market
7D8.6%0.6%-1.8%
1Y-3.7%-26.0%-36.0%

Return vs Industry: EMBLA exceeded the Danish Medical Equipment industry which returned -25% over the past year.

Return vs Market: EMBLA exceeded the Danish Market which returned -35.9% over the past year.

Price Volatility

Is EMBLA's price volatile compared to industry and market?
EMBLA volatility
EMBLA Average Weekly Movement5.2%
Medical Equipment Industry Average Movement5.0%
Market Average Movement4.3%
10% most volatile stocks in DK Market9.0%
10% least volatile stocks in DK Market2.5%

Stable Share Price: EMBLA has not had significant price volatility in the past 3 months compared to the Danish market.

Volatility Over Time: EMBLA's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19714,000Sveinn Solvasonwww.emblamedical.com

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints.

Embla Medical hf. Fundamentals Summary

How do Embla Medical hf's earnings and revenue compare to its market cap?
EMBLA fundamental statistics
Market capDKK 14.63b
Earnings (TTM)DKK 494.70m
Revenue (TTM)DKK 5.75b
29.6x
P/E Ratio
2.5x
P/S Ratio

Is EMBLA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EMBLA income statement (TTM)
RevenueUS$896.78m
Cost of RevenueUS$334.17m
Gross ProfitUS$562.61m
Other ExpensesUS$485.47m
EarningsUS$77.14m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

Feb 03, 2026

Earnings per share (EPS)0.18
Gross Margin62.74%
Net Profit Margin8.60%
Debt/Equity Ratio44.3%

How did EMBLA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/27 08:15
End of Day Share Price 2025/10/27 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Embla Medical hf. is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
null nullABG Sundal Collier Sponsored
Beatrice FairbairnBerenberg